Effects of glutamate transporter inhibitors on the antitumor activity of doxorubicin

Clinical Cancer Research

Volumn 8, Issue 12, 2002, Pages 3943-3947

  Sadzuka, Yasuyuki ^a   Yamashita, Yasuyo ^a   Sonobe, Takashi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROKAINIC ACID; DOXORUBICIN; GLUTAMATE TRANSPORTER;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CONCENTRATION; DRUG EFFECT; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SARCOMA CELL;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ANTINEOPLASTIC AGENTS; DOXORUBICIN; FEMALE; GLUTAMATES; HUMANS; KAINIC ACID; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; NEOPLASMS, EXPERIMENTAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE; TUMOR CELLS, CULTURED;

EID: 0036898940     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sadzuka, Y., Yamashita, Y., Sugiyama, T., and Sonobe, T. Effect of dihydrokainate on the antitumor activity of doxorubicin. Cancer Lett., 179: 157-163, 2002.
2. Sadzuka, Y., Sugiyama, T., Suzuki, T., and Sonobe, T. Enhancement of the activity of doxorubicin by inhibition of glutamate transporter. Toxicol. Lett., 123: 159-167, 2001.
3. +-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. USA, 89: 10955-10959, 1992.
4. Pines, G., Danbolt, N. C., Bjoras, M., Zhang, Y., Bendahan, A., Eide, L., Koepsell, H., Storm-Mathisen, J., Seeberg, E., and Kanner, B. I. Cloning and expression of a rat brain L-glutamate transporters. Nature (Lond.), 360: 464-467, 1992.
5. Kanai, Y., and Hediger, M. A. Primary structure and characterization of high-affinity glutamate transporters. Nature (Lond.), 360: 467-471, 1992.
6. Fairman, W. A., Vandenberg, R. J., Arriza, J. L., Kavanaugh, M. P., and Amara, S. G. An excitatory amino acid transporter with properties of ligand-gated chloride channel. Nature (Lond.), 375: 599-603, 1995.
7. Arriza, J. L., Fairman, W. A., Wadiche, J. I., Murdoch, G. H., Kavanaugh, M. P., and Amara, S. G. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci., 14: 5559-5569, 1994.
8. Arriza, J. L., Eliasof, S., Kavanaugh, M. P., and Amara, S. G. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc. Natl. Acad. Sci. USA, 94: 4155-4160, 1997.
9. Kanai, Y., Smith, C. P., and Hediger, M. A. A new family of transmitter transporters: The high-affinity glutamate transporters. FASEB J., 7: 1450-1459, 1993.
10. Gegelashvili, G., and Shousboe, A. Cellular distribution and kinetic properties of high-affinity glutamate transporters. Brain Res. Bull., 45: 233-238, 1998.
11. +-dependent glutamate transport activity in synaptosomes, C6 gloma, and Xenopus oocytes expressing excitatory amino acid carrier 1(EAAC1). Mol. Phamacol., 49: 465-473, 1996.
12. Velaz-Faircloth, M., McGraw, T. S., Malandro, M. S., Fremeau, R. T., Jr., Kilberg, M. S., and Anderson, K. J. Characterization and distribution of the neuronal glutamate transporter EAAC1 in rat brain. Am. Phys. Soc., 270: C65-C75, 1996.
13. McGivan, J. D. Rat hepatoma cells express novel transporter systems for glutamine and glutamate in addition to those present in normal rat hepatocytes. Biochem. J., 330: 255-260, 1998.
14. Wang, G. J., Chung, H. J., Schnuer, J., Pratt, K., Zable, A. C., Kavanaugh, M. P., and Rosenberg, P. A. High affinity glutamate transport in rat cortical neurons in culture. Mol. Pharmacol., 53: 88-96, 1998.
15. Fine, S. M., Angel, R. A., Perry, S. W., Epstein, L. G., Rothstein, J. D., Dewhurst, S., and Gelbard, H. A. Tumor necrosis factor α inhibits glutamate uptake by primary human astrocytes. J. Biol. Chem., 271: 15303-15306, 1996.
16. Sadzuka, Y., Sugiyama, T., Miyagishima, A., Nozawa, Y., and Hirota, S. The effects of theanine, as a novel biochemical modulator, on the anitumor activity of Adriamycin. Cancer Lett., 105: 203-209, 1996.
17. Sugiyama, T., and Sadzuka, Y. Enhancing effects of green tea components on the antitumor activity of Adriamycin against M5076 ovarian sarcoma. Cancer Lett., 133: 19-26, 1998.
18. Sadzuka, Y., Sugiyama, T., Tanaka, K., and Sonobe, T. Inhibition of glutamate transporter by theanine enhances the therapeutic efficacy of doxorubicin. Toxicol. Lett., 121: 89-96, 2001.